insights_auto
Why is EDIT down 2.41%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.82
arrow_downward
-2.41%(-0.045) 1D
$1.92
arrow_upward
+5.21% (+0.095)bedtimeAfter hours
Closed: Nov 17, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.90
High
$1.94
Low
$1.82
Mkt. cap
281.67M
Avg. vol.
2.41M
Volume
2.10M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.90
High
$1.94
Low
$1.82
Mkt. cap
281.67M
Avg. vol.
2.41M
Volume
2.10M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
TradingView
·
1 hour ago
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
BigGo Finance
·
3 hours ago
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
ChartMill
·
3 hours ago
S&P 500 After-Hours Gainers for Nov. 17, 2026
Traders Union
·
26 minutes ago
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com